List of Excipients in API carbidopa, levodopa and entacapone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbidopa, levodopa and entacapone
Excipients in ANDA-approved (generic) drugs containing carbidopa, levodopa and entacapone
Detailed excipient profiles for carbidopa, levodopa and entacapone
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carbidopa, levodopa and entacapone drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | carbidopa, levodopa and entacapone | 16571-689 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa and entacapone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
carbidopa, levodopa and entacapone drug variants containing CROSCARMELLOSE SODIUM
carbidopa, levodopa and entacapone drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
carbidopa, levodopa and entacapone drug variants containing FERRIC OXIDE RED
carbidopa, levodopa and entacapone drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
carbidopa, levodopa and entacapone drug variants containing FERRIC OXIDE YELLOW
carbidopa, levodopa and entacapone drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
carbidopa, levodopa and entacapone drug variants containing GLYCERIN
carbidopa, levodopa and entacapone drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
carbidopa, levodopa and entacapone drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa, levodopa and entacapone | 0378-8300 |
| Rising Pharma Holdings Inc | carbidopa, levodopa and entacapone | 16571-689 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa and entacapone drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa, levodopa and entacapone | 47335-001 |
| Wockhardt Limited | carbidopa, levodopa and entacapone | 55648-782 |
| Wockhardt USA LLC | carbidopa, levodopa and entacapone | 64679-782 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
carbidopa, levodopa and entacapone drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa, levodopa and entacapone | 47335-001 |
| Wockhardt Limited | carbidopa, levodopa and entacapone | 55648-782 |
| Wockhardt USA LLC | carbidopa, levodopa and entacapone | 64679-782 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa and entacapone drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa, levodopa and entacapone | 0378-8300 |
| Rising Pharma Holdings Inc | carbidopa, levodopa and entacapone | 16571-689 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
carbidopa, levodopa and entacapone drug variants containing MAGNESIUM STEARATE
carbidopa, levodopa and entacapone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
carbidopa, levodopa and entacapone drug variants containing MANNITOL
carbidopa, levodopa and entacapone drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
carbidopa, levodopa and entacapone drug variants containing POLYSORBATE 80
carbidopa, levodopa and entacapone drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
carbidopa, levodopa and entacapone drug variants containing POVIDONE
carbidopa, levodopa and entacapone drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
carbidopa, levodopa and entacapone drug variants containing STARCH, CORN
carbidopa, levodopa and entacapone drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
carbidopa, levodopa and entacapone drug variants containing SUCROSE
carbidopa, levodopa and entacapone drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
carbidopa, levodopa and entacapone drug variants containing TITANIUM DIOXIDE
carbidopa, levodopa and entacapone drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
